TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer

Annals of Surgical Oncology

Volumn 17, Issue 4, 2010, Pages 967-972

  Miyoshi, Norikatsu ^a   Ishii, Hideshi ^a,b   Mimori, Koshi ^b   Tanaka, Fumiaki ^b   Hitora, Toshiki ^a   Tei, Mitsuyoshi ^a   Sekimoto, Mitsugu ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADENOCARCINOMA, MUCINOUS; AGED; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; FEMALE; GTP-BINDING PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77952091768     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0865-y     Document Type: Article

References (33)

1. SI Kohno C Luo A Nawa, et al. 2007 Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus Cancer Gene Ther 14 918 926 10.1038/sj.cgt.7701070 1:CAS:528:DC%2BD2sXhtFChur%2FP 17693992 (Pubitemid 47558955)
2. JE Folk 1980 Transglutaminases Annu Rev Biochem 49 517 531 10.1146/annurev.bi.49.070180.002505 1:CAS:528:DyaL3cXks1ChtLw%3D 6105840
3. L Lorand RM Graham 2003 Transglutaminases: Crosslinking enzymes with pleiotropic functions Nat Rev Mol Cell Biol 4 140 156 10.1038/nrm1014 1:CAS:528:DC%2BD3sXnsFaqtg%3D%3D 12563291 (Pubitemid 36172696)
4. MA Antonyak US Singh DA Lee, et al. 2001 Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis J Biol Chem 276 33582 33587 10.1074/jbc.M105318200 1:CAS:528:DC%2BD3MXmslyls7c%3D 11438548 (Pubitemid 37384572)
5. JE Boehm U Singh C Combs, et al. 2002 Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb J Biol Chem 277 20127 20130 10.1074/jbc.C200147200 1:CAS:528:DC%2BD38XkslWgsL8%3D 11956182 (Pubitemid 34967301)
6. MA Antonyak AM Miller JM Jansen, et al. 2004 Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells J Biol Chem 279 41461 41467 10.1074/jbc.M404976200 1:CAS:528:DC%2BD2cXnvFWhur4%3D 15272014 (Pubitemid 39313586)
7. LS Mangala K Mehta 2005 Tissue transglutaminase (TG2) in cancer biology Prog Exp Tumor Res 38 125 138 10.1159/000084237 1:CAS:528:DC%2BD2MXltVSqsLw%3D 15746533 (Pubitemid 43264961)
8. K Mehta 2005 Mammalian transglutaminases: A family portrait Prog Exp Tumor Res 38 1 18 10.1159/000084229 1:CAS:528:DC%2BD2MXltVSru7s%3D 15746526 (Pubitemid 40301040)
9. AP Mann A Verma G Sethi, et al. 2006 Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: Delineation of a novel pathway Cancer Res 66 8788 8795 10.1158/0008-5472.CAN-06-1457 1:CAS:528:DC%2BD28XovF2hsbg%3D 16951195 (Pubitemid 44449196)
10. Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803-4.
11. K Mimori M Mori T Shiraishi, et al. 1997 Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma Br J Cancer 76 531 536 1:CAS:528:DyaK2sXlvV2nsLc%3D 9275032 (Pubitemid 27331220)
12. M Mori RJ Staniunas GF Barnard, et al. 1993 The significance of carbonic anhydrase expression in human colorectal cancer Gastroenterology 105 820 826 1:STN:280:DyaK3szms1Whuw%3D%3D 8359652 (Pubitemid 23249492)
13. L Fesus M Piacentini 2002 Transglutaminase 2: An enigmatic enzyme with diverse functions Trends Biochem Sci 27 534 539 10.1016/S0968-0004(02)02182-5 1:CAS:528:DC%2BD38XnsVWqsbs%3D 12368090 (Pubitemid 35279599)
14. K Mehta 1994 High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells Int J Cancer 58 400 406 10.1002/ijc.2910580316 1:CAS:528:DyaK2cXlslKgtLc%3D 7914183 (Pubitemid 24254651)
15. JS Chen M Konopleva M Andreeff, et al. 2004 Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis J Cell Physiol 200 223 234 10.1002/jcp.20014 1:CAS:528:DC%2BD2cXlslaqur0%3D 15174092 (Pubitemid 38880206)
16. K Mehta J Fok FR Miller, et al. 2004 Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer Clin Cancer Res 10 8068 8076 10.1158/1078-0432.CCR-04-1107 1:CAS:528:DC%2BD2cXhtVCrs7vO 15585642 (Pubitemid 39587548)
17. JF Herman LS Mangala K Mehta 2006 Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells Oncogene 25 3049 3058 10.1038/sj.onc.1209324 1:CAS:528:DC%2BD28Xks1OrsLw%3D 16449978 (Pubitemid 43780469)
18. Z Sarang P Molnar T Nemeth, et al. 2005 Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice Hepatology 42 578 587 10.1002/hep.20812 1:CAS:528:DC%2BD2MXhtVemt7zJ 16108039 (Pubitemid 41233650)
19. D Aeschlimann M Paulsson 1994 Transglutaminases: Protein cross-linking enzymes in tissues and body fluids Thromb Haemost 71 402 415 1:CAS:528:DyaK2cXksl2jt7g%3D 7914385 (Pubitemid 24100662)
20. D Aeschlimann MK Koeller BL Allen-Hoffmann DF Mosher 1998 Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers J Biol Chem 273 3452 3460 10.1074/jbc.273.6.3452 1:CAS:528:DyaK1cXhtVymsro%3D 9452468 (Pubitemid 28109765)
21. JS Chen K Mehta 1999 Tissue transglutaminase: An enzyme with a split personality Int J Biochem Cell Biol 31 817 836 10.1016/S1357-2725(99)00045-X 1:CAS:528:DyaK1MXls1yrsbk%3D 10481269 (Pubitemid 29354079)
22. CS Greenberg PJ Birckbichler RH Rice 1991 Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues FASEB J 5 3071 3077 1:CAS:528:DyaK38XnvV2hsQ%3D%3D 1683845
23. L Ai WJ Kim B Demircan, et al. 2008 The transglutaminase 2 gene (TGM2.), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer Carcinogenesis 29 510 518 10.1093/carcin/bgm280 1:CAS:528:DC%2BD1cXjsVamsLg%3D 18174247 (Pubitemid 351404866)
24. T Andre E Quinaux C Louvet, et al. 2007 Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: Final results of GERCOR C96.1 J Clin Oncol 25 3732 3738 10.1200/JCO.2007.12.2234 1:CAS:528: DC%2BD2sXhtVeqt7fK 17704423 (Pubitemid 47372615)
25. BM Wolpin RJ Mayer 2008 Systemic treatment of colorectal cancer Gastroenterology 134 1296 1296 10.1053/j.gastro.2008.02.098 1:CAS:528: DC%2BD1cXntVWhtL0%3D 18471507 (Pubitemid 351615376)
26. M Kornmann A Formentini C Ette, et al. 2008 Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment Eur J Surg Oncol 34 1316 1321 1:STN:280:DC%2BD1cjhsFCjug%3D%3D 18313881
27. OF Bathe S Dowden F Sutherland, et al. 2004 Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma BMC Cancer 4 32 10.1186/1471-2407-4-32 15245580 (Pubitemid 40180254)
28. AM Lacy JC Garcia-Valdecasas S Delgado, et al. 2002 Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial Lancet 359 2224 2229 10.1016/S0140-6736(02)09290-5 12103285 (Pubitemid 34717975)
29. JC Weeks H Nelson S Gelber, et al. 2002 Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: A randomized trial JAMA 287 321 328 10.1001/jama.287.3.321 11790211 (Pubitemid 34251965)
30. Group COoSTS 2004 A comparison of laparoscopically assisted and open colectomy for colon cancer N Engl J Med 350 2050 2059 10.1056/NEJMoa032651 (Pubitemid 38596556)
31. DG Jayne PJ Guillou H Thorpe, et al. 2007 Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group J Clin Oncol 25 3061 3068 10.1200/JCO.2006.09.7758 17634484 (Pubitemid 47224732)
32. JA Han SC Park 1999 Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line J Cancer Res Clin Oncol 125 89 95 10.1007/s004320050247 1:CAS:528:DyaK1MXitVOmtL8%3D 10190315 (Pubitemid 29161460)
33. E Devarajan J Chen AS Multani, et al. 2002 Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features Int J Oncol 20 913 920 1:CAS:528:DC%2BD38XktVSmt7s%3D 11956583